"Asia-Pacific Lentiviral Vector Market Summary: According to the latest report published by Data Bridge Market Research, the Asia-Pacific Lentiviral Vector Market The Asia-Pacific Lentiviral Vector Market size was valued at USD 132.51 billion in 2025 and is expected to reach USD 437.42 billion by 2033, at a CAGR of 16.10% during the forecast period Asia-Pacific Lentiviral Vector...

The expanding field of gene therapy is creating strong demand for advanced viral delivery systems across the healthcare industry. Biotechnology companies and research institutions are increasingly focusing on therapies targeting rare genetic disorders and oncology applications. Lentiviral vectors have emerged as a reliable platform for stable gene transfer, enabling long-term therapeutic...

Viral vector manufacturing involves producing viral vectors used in gene therapy and cell therapy to deliver therapeutic genes into patient cells. The global viral vector manufacturing market size was valued at USD 267.8 million in 2024 and is expected to grow from USD 336.36 million in 2025 to USD 3189.15 million by 2033, growing at a CAGR of 19.7% during the forecast period...